Tag: eli_lilly
-
Drugmakers Say GLP-1 Weight-Loss Drugs Show Signs of Slowing Biological Aging
Eli Lilly and Novo Nordisk report a roughly two- to three-year reduction in biological age, while researchers continue to probe side effects including hair loss, nail disorders and a disputed vision-loss link.
Science & TechnologyHealthBusinessPolitics and GovernmentArtificial IntelligenceMedical ScienceEnergyComputers and InternetMilitaryLegalUSASocial IssuesPharmaceuticalsEnvironmentClimate ChangeEconomy MIT Technology ReviewAI refusalGLP-1 weight-loss drugsEnvision EnergyAnthropic ClaudeOpenAI revenue forecastMITsciencetechnologyGLP-1 drugsbiological ageEli LillyNovo Nordiskweight lossWorld Health Organizationchildhood obesityOpenAIMistralGoogle data center Finlandbiological agingaging clockssemaglutide
-
Media Monitor: TIME Health Reports Weight-Loss Pill Results, Nursing Home Evacuations
TIME Health reports Eli Lilly's weight-loss pill Foundayo cut Type 2 diabetes risk by 57%, plus Minnesota nursing home evacuations and a gratitude journaling alternative.
HealthBusinessWeatherMedical ScienceDisastersSocial Issues TIME HealthEli LillyFoundayoweight-loss pillType 2 diabetesMinnesota nursing home evacuationsreverse bucket list
-
Media Monitor: TIME Health Reports on Doctor Communication, Drug Shortages, Telehealth "Pill Mills"
TIME Health reports on a study about doctor-patient communication, persistent chemotherapy drug shortages, and a Senate investigation into telehealth "pill mills." It also covers Eli Lilly's lawsuit and tips for runners.
HealthBusinessPolitics and GovernmentLaw EnforcementMedical ScienceEconomyFederal GovernmentLegalSocial Issues TelehealthDrug ShortagesCancerMedical CommunicationCivicaEli LillyWeight-loss DrugTIME Health
-
Governor Ivey Honors Alabama Manufacturers on 'Made in the USA' Day
Governor Kay Ivey celebrated Alabama's manufacturing sector on "Made in the USA" Day, highlighting its 280,000 workers, $23 billion in exports, and major investments like Eli Lilly's $6 billion plant, solidifying the state's role in the national economy.
Politics and GovernmentBusinessScience & TechnologyState GovernmentsEconomyEmployment and LaborMedical ScienceEducation Kay IveyAlabamaManufacturingMade in the USA DayEconomic GrowthEli LillyExportsAlabama Governor's Office
-
Alabama Honored with Silver Shovel Award for Economic Growth
Alabama secured a 2026 Silver Shovel Award from Area Development, recognizing significant economic growth driven by U.S. Space Command's presence and Eli Lilly's $6 billion pharmaceutical investment in Huntsville, alongside record-breaking statewide investments.
BusinessPolitics and GovernmentScience & TechnologyEconomyState GovernmentsFederal GovernmentMedical ScienceAstronomy and SpaceEmployment and Labor AlabamaSilver Shovel AwardEconomic DevelopmentHuntsvilleU.S. Space CommandEli LillyPharmaceuticalsAlabama Governor's Office
-
Media Monitor: Washington Post Reports on New Weight Loss Drug, Congressional Absence, and Fair Performer Withdrawals
The Washington Post is reporting on Eli Lilly's experimental GLP-1 drug, Rep. Tom Kean Jr.'s absence from Congress, and performer withdrawals from the Great American State Fair.
HealthPolitics and GovernmentEntertainmentBusinessMedical ScienceGeneral PoliticsCongressSocial IssuesMusic Eli LillyGLP-1Tom Kean Jr.Great American State FairPoliticsWeight LossThe Washington Post
-
Media Monitor: SpaceX IPO, Meta's New App, Airbnb Expansion, and Eli Lilly Drug News
The Rundown reports on SpaceX's IPO structure, Meta's new Reddit-style app, Airbnb's expanded travel services, and Eli Lilly's experimental obesity drug, retatrutide, which is raising questions due to its extreme effectiveness.
BusinessScience & TechnologyHealthMediaEconomyComputers and InternetArtificial IntelligenceMedical ScienceAstronomy and SpaceLegal SpaceXElon MuskMetaAirbnbEli LillyRetatrutideTechnologyThe Rundown
-
Media Monitor: Eli Lilly's New Weight-Loss Drug Shows Dramatic Results
TIME is reporting that Eli Lilly's experimental weight-loss drug achieved significant body weight reduction in trials, comparable to bariatric surgery, without increased side effects.
HealthBusinessScience & TechnologyMedical Science Eli Lillyweight lossobesitypharmaceuticalsdrug developmenthormonesTIME Health